167 related articles for article (PubMed ID: 17921723)
21. Establishment and characterization of multi-drug resistant, prostate carcinoma-initiating stem-like cells from human prostate cancer cell lines 22RV1.
Liu T; Xu F; Du X; Lai D; Liu T; Zhao Y; Huang Q; Jiang L; Huang W; Cheng W; Liu Z
Mol Cell Biochem; 2010 Jul; 340(1-2):265-73. PubMed ID: 20224986
[TBL] [Abstract][Full Text] [Related]
22. Cancer stem cells: Models, mechanisms and implications for improved treatment.
Zhou J; Zhang Y
Cell Cycle; 2008 May; 7(10):1360-70. PubMed ID: 18418062
[TBL] [Abstract][Full Text] [Related]
23. The role of stem cell markers in multidrug resistance mediated by ABC transporters.
Tiwari AK; An X; Chen ZS
Leuk Res; 2010 Jun; 34(6):696-7. PubMed ID: 20061021
[No Abstract] [Full Text] [Related]
24. Possible role of mural cell-covered mature blood vessels in inducing drug resistance in cancer-initiating cells.
Matsui T; Kinugasa Y; Tahara H; Kanakura Y; Takakura N
Am J Pathol; 2013 May; 182(5):1790-9. PubMed ID: 23473746
[TBL] [Abstract][Full Text] [Related]
25. Mechanisms of multidrug resistance in cancer.
Gillet JP; Gottesman MM
Methods Mol Biol; 2010; 596():47-76. PubMed ID: 19949920
[TBL] [Abstract][Full Text] [Related]
26. MicroRNA-199a targets CD44 to suppress the tumorigenicity and multidrug resistance of ovarian cancer-initiating cells.
Cheng W; Liu T; Wan X; Gao Y; Wang H
FEBS J; 2012 Jun; 279(11):2047-59. PubMed ID: 22498306
[TBL] [Abstract][Full Text] [Related]
27. Enhancing chemosensitivity in ABCB1- and ABCG2-overexpressing cells and cancer stem-like cells by an Aurora kinase inhibitor CCT129202.
Cheng C; Liu ZG; Zhang H; Xie JD; Chen XG; Zhao XQ; Wang F; Liang YJ; Chen LK; Singh S; Chen JJ; Talele TT; Chen ZS; Zhong FT; Fu LW
Mol Pharm; 2012 Jul; 9(7):1971-82. PubMed ID: 22632055
[TBL] [Abstract][Full Text] [Related]
28. Impact of breast cancer resistance protein on cancer treatment outcomes.
Ross DD; Nakanishi T
Methods Mol Biol; 2010; 596():251-90. PubMed ID: 19949928
[TBL] [Abstract][Full Text] [Related]
29. Cancer stem cell targeting: are we there yet?
Jung Y; Kim WY
Arch Pharm Res; 2015 Mar; 38(3):414-22. PubMed ID: 25666873
[TBL] [Abstract][Full Text] [Related]
30. Downregulation of ABCG2 expression in glioblastoma cancer stem cells with miRNA-328 may decrease their chemoresistance.
Li WQ; Li YM; Tao BB; Lu YC; Hu GH; Liu HM; He J; Xu Y; Yu HY
Med Sci Monit; 2010 Oct; 16(10):HY27-30. PubMed ID: 20885358
[TBL] [Abstract][Full Text] [Related]
31. Implications of cancer stem cells in the treatment of cancer.
Pan CX; Zhu W; Cheng L
Future Oncol; 2006 Dec; 2(6):723-31. PubMed ID: 17155899
[TBL] [Abstract][Full Text] [Related]
32. Mouse ATP-Binding Cassette (ABC) Transporters Conferring Multi-Drug Resistance.
Li S; Zhang W; Yin X; Xing S; Xie HQ; Cao Z; Zhao B
Anticancer Agents Med Chem; 2015; 15(4):423-32. PubMed ID: 25929575
[TBL] [Abstract][Full Text] [Related]
33. Molecular biology. Cancer's perpetual source?
Marx J
Science; 2007 Aug; 317(5841):1029-31. PubMed ID: 17717165
[No Abstract] [Full Text] [Related]
34. Factors influencing development of new therapeutics for oncology.
Winquist RJ; Boucher DM
Curr Opin Pharmacol; 2010 Aug; 10(4):353-5. PubMed ID: 20634136
[No Abstract] [Full Text] [Related]
35. Effect of ceritinib (LDK378) on enhancement of chemotherapeutic agents in ABCB1 and ABCG2 overexpressing cells in vitro and in vivo.
Hu J; Zhang X; Wang F; Wang X; Yang K; Xu M; To KK; Li Q; Fu L
Oncotarget; 2015 Dec; 6(42):44643-59. PubMed ID: 26556876
[TBL] [Abstract][Full Text] [Related]
36. Drug Transporter-Mediated Protection of Cancer Stem Cells From Ionophore Antibiotics.
Boesch M; Zeimet AG; Rumpold H; Gastl G; Sopper S; Wolf D
Stem Cells Transl Med; 2015 Sep; 4(9):1028-32. PubMed ID: 26136502
[TBL] [Abstract][Full Text] [Related]
37. ABCG2: a potential marker of stem cells and novel target in stem cell and cancer therapy.
Ding XW; Wu JH; Jiang CP
Life Sci; 2010 Apr; 86(17-18):631-7. PubMed ID: 20159023
[TBL] [Abstract][Full Text] [Related]
38. Targeting cancer stem cell-specific markers and/or associated signaling pathways for overcoming cancer drug resistance.
Ranji P; Salmani Kesejini T; Saeedikhoo S; Alizadeh AM
Tumour Biol; 2016 Oct; 37(10):13059-13075. PubMed ID: 27561758
[TBL] [Abstract][Full Text] [Related]
39. Cancer stem cells: a step toward the cure.
Boman BM; Wicha MS
J Clin Oncol; 2008 Jun; 26(17):2795-9. PubMed ID: 18539956
[No Abstract] [Full Text] [Related]
40. The Hedgehog pathway as a drug target in cancer therapy.
Lauth M; Toftgård R
Curr Opin Investig Drugs; 2007 Jun; 8(6):457-61. PubMed ID: 17621875
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
